Sensus Healthcare Q1 revenue drops to $3.4M; cash $18.3M, no debt

Sensus Healthcare, Inc.

2026-Q1 EPS reported -$0.16 revenue$3,394,000

Revenue of $3.4M, down 59% vs $8.3M in Q1 2025; no sales to historically largest customer (15 units in prior year).
Shipped 14 SRT systems (10 direct, 4 placements) vs 30 in prior year; excluding largest customer sales, revenue up from $2.7M.
Gross margin fell to 29.2% from 52.2% due to product mix and Fair Deal placements; adjusted EBITDA -$4.2M vs -$2.5M.
New CPT codes for SRT effective Jan 1, 2026 drove higher inquiry levels and pipeline activity.
Launched Sensus Healthcare Financial Services and Sensus Link; Fair Deal treatment volumes up 8% YoY.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

Sensus Healthcare, Inc. reported the three months ended March 31, 2026 results: revenue $3.4 million.

Period: the three months ended March 31, 2026
Revenue: $3.4 million
Result: reported results

Exact text from the filing

and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights included: ● Revenue of $3.4 million compared to $8.3 million for the three months ended March 31, 2025. o Excluding sales to the Company’s historically largest customer, revenue increased from $2.7 million in the

View on SEC.gov

Browse all earnings releases →

Sensus Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001753926-26-000782

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.